Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2017-01-12

Clinical Trial Update: Effectiveness of Naltrexone and Lofexidine in Treating Detoxified Heroin Addicts - 1 [Phase 1]

View source ↗

Summary

A Phase 1 trial sponsored by the National Institute on Drug Abuse evaluated the effectiveness of naltrexone and lofexidine for detoxified opioid dependence. The…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • LOFEXIDINE (LOFEXIDINE)
  • Naltrexone (Naltrexone)

Snippet

Sponsor: National Institute on Drug Abuse (NIDA) | Conditions: Heroin Dependence | Phase 1 | Status: COMPLETED